http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
개별검색 DB통합검색이 안되는 DB는 DB아이콘을 클릭하여 이용하실 수 있습니다.
통계정보 및 조사
예술 / 패션
<해외전자자료 이용권한 안내>
- 이용 대상 : RISS의 모든 해외전자자료는 교수, 강사, 대학(원)생, 연구원, 대학직원에 한하여(로그인 필수) 이용 가능
- 구독대학 소속 이용자: RISS 해외전자자료 통합검색 및 등록된 대학IP 대역 내에서 24시간 무료 이용
- 미구독대학 소속 이용자: RISS 해외전자자료 통합검색을 통한 오후 4시~익일 오전 9시 무료 이용
※ 단, EBSCO ASC/BSC(오후 5시~익일 오전 9시 무료 이용)
Syntax notation one (ASN.1) defined by ITU-T and ISO, is a formal abstrct specification language which has been widely used in international standards specifiation to inteconnect distributed open systems. It si necessary to have well defined encoder/decoder modules which taranslate ASN.1 datum to BER octets stream to interconnect distributed open systems. In this paper, we designed and implemented a new ASN.1-to-C compiler, called HYASNC (hanyang ASN.1-to-C), which atutomatically translates and ASN.1-to-C compiler, called HYASNC (hanyang ASN.1-to-C), which automatically translates an ASN.1 specification into C-language BER encoders and decoders with simple and neat I/F for the defined ASN.1 data types, and enhanced BER (basic encoding rules)encoding/decoding libraries, called HY(hanyang)BER library, and useful utility functions. And this paper discusses HYASNC compiler, HY BER runtime library's design and implementation principles, and also evaluates the perfomrance of HY BER library and the interoperability with other ASN.1 compilers.
Administration of gonadotropin hormone-releasing hormone(GnRH) agonist, through a process of pituitary desensitization and down-regulation of receptors, inhibits the secretion of gonadotropin and sex-steroids and induces a reversible suppression of gonadal activity. This approach can be used as an effective endocrine therapy for some hormone-dependent tumors. We have used GnRH agonist, for the treatment of four patients with uterine leiomyomas, thereafter myometomy was performed in all cases To assess the effect of treatment with GnRH agonist, ultrastructural changes of the tumor cells of leiomyoma are studied, along with measurement of changes in serum hormone levels (LH, FSH, and E2) and the sizes of the neoplasm . Electron microscopic findings of myoma cells after the use of GnRH agonist included the following : increased mitochondria, swelling of mitochondria with loss of cristae, clumping of nuclear chromatin, dilation of endoplasmic reticulum and perinuclear vacuolation, and loss myofilaments. The use of GnRH agonist may be effective in reducing the size of a myoma considerably by primarily inducing medical hypophysectomy and would allow easier surgical removal.
Menopause is an event common to all women. For some women, it is not difficult, but for many it arrives with complication, both physiological and psychological. Although there is perhaps no gynecologic disorder in which the indication for hormone therapy is more rational than in the treatment of typical climacteric symptoms, especially the vasomotor group, it must be remembered that many symptoms frequently observed in menopausal women are not directly due to the endocrine readjustments of this period but are more logically explained as due to environmental and psychogenic factors. Estrogen therapy is indicated for the control of acute symptoms of the hot flush and insomnia. If treated soon after onset with adequate dosage, the symptoms can usually be controlled rapidly. As the menopausal woman is not totally estrogen deficient, but only relatively deficient in respect to reproductive capacity. some women will not need constant low-dose estrogen replacement therapy as indicated in the premature menopausal patient. Prophylactic estrogen therapy for the prevention of arteriosclerotic cardiovascular disease may be needed. For the patient at risk for osteoporosis, low-dose prophylactic estrogen therapy may be needed. The action of estrogen on bone is to prevent calcium resorption, and there is little evidence that it will stimulate new bone formation. The two cardinal principles of hormon therapy are most important in such long-term treatment, as little "as necessary to control symptoms over as short as possible a duration" Consequently, today a healthy fifty-year-old women can resonably expect to live for another thirty to forty years.
본 실험은 우리 주변에서 흔히 볼 수 있는 몇가지 야생초화류의 절간신장 및 엽면적 변화에 미치는 Uniconazol의 영향을 구명하여 화단 및 화분용으로의 이용 가능성을 알아보기 위하여 실시되었으며 그 결과는 다음과 같다. 1. Uniconazol 처리후 절간신장이 억제되는 경향을 보였고 그 억제효과는 처리농도가 높을수록 커지는 경향을 보였으며 처리농도에서 약해를 나타내지 않았다. 등골나물과 함박꽃에서는 뚜렷한 처리효과가 나타나지 않았다. 도라지, 부처꽃, 산국에서는 처리효과가 오래 지속되지 않았으므로 2차 처리가 필요한 것으로 나타났다. 2. Uniconazol처리후 엽면적이 감소하는 경향을 보였으며 그 억제효과는 처리농도가 높아질수록 커지는 경향을 보였다. 엽장/엽폭의 비율은 뚜렷한 경향이 나타나지 않았다. 3. 개화에 미치는 Uniconazol의 영향은 추후 연구대상이 되겠으나 처리후 절간신장 및 잎의 생장이 억제되는 것으로 보아 야생초화류이 화단 및 화분용으로서의 이용 가능성이 높은 것으로 생각된다. There are many wild flowers in Korea which have good quality as ornamental plants. But the plant height of the flowers is so high that plant height should be reduced for the use as garden and pot flowers. So some growth retardant might be used to reduced plant height and leaf size of the flowers. This study was conducted to determine the effect of Uniconazol on the growth of some wild flowers. Plant height was reduced by Uniconazol treatment, and the effect increased with increasing concentration. There was no effect of Uniconazol on Deunggol-namul and Hambakggot. It was suggested that second treatment might be necessary on Doraji, Bucheo-ggot, and San-guk because retardant effect did not continued after 21 day from treatment. Leaf width and length also reduced by Uniconazol treatment, and the effect increased with increasing concentration. According to these results, Uniconazol is effective to reduce the plant height and leaf size of these wild flowers, and the effect of Uniconazol on the flowering should be determined to confirm how to use Uniconazol on these wild flowers for the use as garden and pot flowers.